<DOC>
	<DOCNO>NCT01261260</DOCNO>
	<brief_summary>On dual basis finding indicate GABA increase follow acute eight week SSRI/dopamine agonist administration indicate GABA-ergic effect follow 14 day pyrimidine administration , purpose study ass follow hypothesis : 1 . Relative placebo , oral dose 1g uridine BID seven day increase brain GABA level sample healthy , unmedicated adult male ; 2 . Relative placebo , oral dose 1g uridine BID seven day increase NTP level sample healthy , unmedicated adult male ; 3 . Brain GABA level directly correlate high energy phosphate level sample healthy , unmedicated adult male .</brief_summary>
	<brief_title>Effect Uridine GABA High Energy Phosphate Levels Healthy Volunteers</brief_title>
	<detailed_description>Based prior MRS study group well work others , hypothesize oral administration uridine actuate increase brain gamma-amino butyric acid ( GABA ) level , along beta-nucleotide triphosphate ( ß-NTP ) level , compare baseline . Our aim investigate specific neuropharmacological effect demonstrate suitability novel magnetic resonance spectroscopy protocol . Our rationale include consideration clinical utility intervention demonstrably effective elevate brain GABA high energy phosphate level broad , since lower GABA bioenergetic state associate plurality affective , anxiety , substance use disorder . On dual basis finding indicate GABA increase follow acute eight week SSRI/dopamine agonist administration note GABA-ergic effect 14 day pyrimidine administration , hypothesize oral dose 2g uridine per day seven day increase brain GABA level sample healthy , unmedicated adult male . We also hypothesize 2g dose uridine per day 7 day increase ß-NTP level , , increase GABA high energy phosphate level correlate . Of note , phosphorylation glutamic acid decarboxylase ATP significantly increase activity enzyme , reponsable synthesis GABA . This choice time period allow determination time course efficacy acute extend range , , therapeutic dosage level uridine yet establish , future study hope determine optimal dosage uridine increase brain GABA ß-NTP level .</detailed_description>
	<criteria>Male Age range 1860 year BMI 18.5 28 Medicationfree Capable providing inform consent Non smoke minimum one year Meets DSMIV criterion Axis I disorder ( past present ) Global assessment functioning ( DSM IV TR ) less 50 Age less 18 great 60 BMI low 18.5 high 28 Any history Alcohol substance dependence abuse accord DSMIV criterion ( except caffeine dependence ) Any medical condition opinion investigator may effect mood symptom Any individual current mood disturbance ( define DSMIVR criterion ) Use cigarette nicotinecontaining product Allergy contraindication uridine Individuals unable comply instruction procedure study History significant head trauma Claustrophobia contraindication MRI ( e.g. , pacemaker , metal fragment ) Any illicit substance use past thirty day Any past treatment substance abuse Any past hospitalization mental illness .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>uridine</keyword>
	<keyword>gamma-amino butyric acid</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Magnetic Resonance Spectroscopy</keyword>
	<keyword>Proton Echo-Planar Spectroscopic Imaging</keyword>
</DOC>